durvalumab - CAS 1428935-60-7
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C6502H10018N1742O2024S42
Molecular Weight:
146.3
COA:
Inquire
Targets:
PD-L1
Description:
Durvalumab is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody. It was approved by FDA for the treatment of patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum-containing chemotherapy, or whose disease has progressed within 12 months of receiving platinum-containing chemotherapy before or after surgery.
Publictions citing BOC Sciences Products
  • >> More
Brife Description:
human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody
Synonyms:
Imfinzi
MSDS:
Inquire
Application:
the treatment of locally advanced or metastatic urothelial carcinoma
Current Developer:
AstraZeneca
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related PD-L1 Products


MSB-0010718C

A human immunoglobulin G1 (IgG1) monoclonal antibody binds to PD-L1 and prevents the interaction of PD-L1 with its receptor PD-1, with potential immune checkpoi...

PD-1/PD-L1 Inhibitor 1
(CAS: 1675201-83-8)

PD-1/PD-L1 Inhibitor 1, is an inhibitor of the PD-1 /PD-Ll protein/protein interaction.

BMS-936559

Anti-PD-L1 monoclonal antibody BMS-936559 binds to PD-L1, blocking its binding to and activation of its receptor programmed death 1 (PD-1), which may enhance th...

durvalumab
(CAS: 1428935-60-7)

Durvalumab is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody. It was approved by FDA for the treatment of patients with locally advanced or metasta...

CA-170

A first-in-class oral, small molecule antagonist of PD-L1, PD-L2 and V-region immunoglobulin-containing suppressor of T cell activation (VISTA).

MPDL3280A
(CAS: 1380723-44-3)

A human, Fc optimized, monoclonal antibody directed against the protein ligand PD-L1 (programmed cell death-1 ligand 1), with potential immune checkpoint inhibi...

CAS 1673534-76-3 PD-1-IN-1

PD-1-IN-1
(CAS: 1673534-76-3)

PD-1-IN-1 is an inhibitor of programmed cell dealth-1 (PD-1).

avelumab
(CAS: 1537032-82-8)

Avelumab is a human monoclonal antibody that is commonly used in immunotherapy and originally for non-small-cell lung carcinoma (NSCLC). It binds to the program...

Quick Inquiry

Verification code

Featured Items